Nurix Therapeutics Inc (NRIX)

EBITDA Growth

794.60%

Quarterly · Period ending:

NRIX logo

NRIX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported794.60%
NRIX Quarterly EBITDA YoY % (-442.36% → 794.60%)
High-resolution chart · PNG

NRIX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nurix Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
794.6021%
-128.5638%
-59.6959%
-35.6798%
-82.0359%
6.8327%
-39.1129%
-41.988%
-33.127%
-92.7282%
0.0346%
12.5481%
21.5422%
51.03%
6.7701%
-29.9652%
-51.7846%
-65.9707%
-68.6838%
-73.5643%
-51.3411%
-102.3479%
-97.9688%
-48.7822%
-806.7121%
-392.269%
-442.3561%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.